Press Releases

Results found (119)
November 2, 2011
Yissum Out-licenses a Breakthrough Seed Improvement Technology to Morflora

The novel technology has been proven effective in a number of plant species

October 4, 2011
General Motors and Yissum Sign Research Collaboration Agreement

The first research funded focuses on forecasting of car sales

July 28, 2011
Yissum Introduces Novel Markers for Brain Cancer Survival Prognosis and a...

The biomarkers discovered by Dr. Karni and the post-doctoral researcher Dr. Regina Golan-Gerstel from the Department of Biochemistry and Molecular Biology are more precise than existing markers, and enable accurate survival prognosis of...

June 27, 2011
Biolinerx signs exclusive license agreement with Yissum for oral phase ii...

BL-7040 has dual activity on both the nervous and immune systems, rendering it highly suitable for treating both neurological diseases and immune system related conditions such as inflammatory or autoimmune diseases. It was invented by HUJI...

June 21, 2011
YISSUM PRESENTS A VIRTUAL CANE FOR THE VISUALLY IMPAIRED

The device was presented for the 1st time at the Israeli Presidential Conference, which is held in collaboration with the Hebrew University of Jerusalem

June 21, 2011
Three senior Hebrew University faculty members to receive Kaye Awards for...

Prof. Haim Rabinowitch, Prof. Dan Gazit and Dr. Raanan Fattal were all awarded the prestigious Kaye Award which is dedicated to encourage faculty, staff, and students of the Hebrew University to develop innovative methods and inventions with good...

June 21, 2011
THREE SENIOR HEBREW UNIVERSITY FACULTY MEMBERS TO RECEIVE KAYE AWARDS FOR...

Prof. Haim Rabinowitch, Prof. Dan Gazit and Dr. Raanan Fattal were all awarded the prestigious Kaye Award which is dedicated to encourage faculty, staff, and students of the Hebrew University to develop innovative methods and inventions with good...

April 12, 2011
YISSUM PRESENTS PROMISING PRE-CLINICAL RESULTS FOR ORAL DELIVERY OF THE...

The technology, invented by Professor Simon Benita, Head of Institute for Drug Research, the School of Pharmacy, enables controlled drug release and increased bioavailability of orally administered lipophilic drugs.

March 16, 2011
HEBREW UNIVERSITY, TEL AVIV UNIVERSITY AND THE TECHNION SIGN LONG TERM...

Researchers from the Hebrew University, Tel Aviv University and Technion will conduct 20 research projects related to electronic auctions and markets

March 7, 2011
YISSUM AND HADASIT LICENSE REGENERATIVE POLYMERIC MEMBRANE IMPLANTS TO...

Pre-clinical trial shows excellent healing and complete bone repair 8 weeks post–osteotomy

February 21, 2011
YISSUM AND DANZIGER INNOVATIONS INTRODUCE A REVOLUTIONARY METHOD FOR...

The novel method uses a modified plant virus in order to transiently infect the plant tissues and cells with genes that encode a special enzyme that is able to permanently change the plant genome in predetermined regions and in a specific manner.

January 31, 2011
YISSUM AND VAXAN TO COLLABORATE FOR THE DEVELOPMENT OF A NOVEL NANOPARTICLE...

These inks can be utilized in a variety of printing technologies, including inkjet printing .The novel conductive inks were invented by Professor Shlomo Magdassi, Dr. Alexander Kamyshny and Michael Grouchko from the Institute of Chemistry at the...